Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine

Click Ther­a­peu­tics Secures $30M in Growth Cap­i­tal from K2 HealthVen­tures to Expand Oper­a­tions (press release): Click Ther­a­peu­tics, Inc. (“Click”), a leader in Dig­i­tal Ther­a­peu­tics™ solu­tions as pre­scrip­tion med­ical treat­ments, today announced $30 mil­lion in debt financ­ing from K2 HealthVen­tures (K2HV), a health­­care-focused spe­cial­ty finance com­pa­ny, to accel­er­ate com­mer­cial­iza­tion of its lead­ing smok­ing ces­sa­tion solu­tion, Clickotine™,…

Read More

On the convergence of neuroscience and electronic engineering

To under­stand the brain you need elec­tron­ic engi­neers too (The Con­ver­sa­tion): “Elec­tron­ic engi­neers are emerg­ing as impor­tant con­trib­u­tors to under­stand­ing of the work­ings of the human brain. There is a rapid­ly grow­ing inter­sec­tion between elec­tron­ic engi­neer­ing and neuroscience. 

Read More